Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Altamira Therapeutics Ltd
CYTOF
Healthcare
Biotechnology
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery...
platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:CYTOF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 23, 2024 10:22am
CYTO.... How are all you Chasers doing????
Are you averaging down now??? Over 40 million shares have traded and all you get is 46 cents What a laugher this is
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 23, 2024 9:06am
CYTO.....early a.m runner up on NR this a.m...but
Go ahead and chase this.......you're all going to get screwed Here is why...... https://www.sec.gov/Archives/edgar/data/1601936/000121390024033817/ea0203993-424b4_altamira.htm
RVV Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
posted Jan 09, 2025 9:00am by
Revive Therapeutics Ltd
-
|
Over the next few weeks data will be collected and analysed for effect size. Should the data show significant effects, Revive and the DRDC will discuss on the future development path. The results from this research study, if promising, will determine further studies to facilitate FDA and Health Canada approvals for the use of Bucillamine in nerve agents or organophosphate pesticide poisoning and explore its potential for traumatic brain injury caused by concussive or explosive forces and viral infections. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 24, 2024 8:47am
New Press Release - Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013) Corroborated by statistically...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 10, 2024 8:00am
New Press Release - Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDTRNA delivery business progressing with new collaborations, potential new applicationsPartnering of legacy assets underway as Company transitions to focused RNA delivery...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 04, 2024 8:45am
New Press Release - Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it will host its Full Year 2023 Financial...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 25, 2024 3:43pm
CYTO......called this almost to the T
Now hear this !!!!!!! FWIW.....I see a pump during AH......It will be quick....so make sure you bid whack JMHO Me...no position And I mean...ever again til the P.O is announced and retraced
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 25, 2024 2:16pm
RE:RE:RE:CYTO....in PB mode
Not 2 bags ; ) 2 cents off the Low of Day Not a bad call ...all considering ; ) I get zero likes for being right again.....u sure r a tough audience to please
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 25, 2024 2:01pm
CYTO..... N.L.O.D...now $2.16
Sheesh
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 25, 2024 1:41pm
RE:RE:CYTO.....This is what I'm thinking now...FWIW ; )
And like I said....don't expect too much ; ) Now looking at "the big picture".......almost 60 million shares have traded and all you get is a paltry 58 cent profit???? Whats wrong with
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 25, 2024 1:36pm
RE:CYTO.....This is what I'm thinking now...FWIW ; )
Pop goes the weasel !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 25, 2024 12:53pm
CYTO.....This is what I'm thinking now...FWIW ; )
I would have to think that there will be 1 more ramp up....If u have a Gambling addiction...pick a spot sub $2.20....watch for some "sideways action" Place a bet...just don't expect too
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 25, 2024 12:26pm
RE:RE:RE:CYTO....in PB mode
Well...we're almost there!!!!! Wait for the announcement folks
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 25, 2024 12:17pm
CYTO.... N.L.O.D $2.26 now
May as well say it now........ All the a.m Chasers have all been had..... AGAIN !!!!!!
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 25, 2024 11:58am
CYTO...all the DT'ers are thinking 2x's tap on L.O.D
I don't think so....hurry up and Dye Maddapakka
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 25, 2024 10:56am
RE:CYTO....start the drumroll !!!!!!!
$2.51...... N.L.O.D now
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Global Tungsten Market Overview and Supply Security
LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine